$15.12
2.36%
Nasdaq, Sep 25, 04:00 pm EDT. Closed.
ISIN
US5907171046
Symbol
MESO

Mesoblast Limited Sponsored ADR Target price 2026 - Analyst rating & recommendation

Mesoblast Limited Sponsored ADR Classifications & Recommendation

Buy
90%
Hold
10%

Mesoblast Limited Sponsored ADR Price Target

Target Price $2.55
Price $15.12
Deviation
Number of Estimates 4
4 Analysts have issued a price target Mesoblast Limited Sponsored ADR 2027 . The average Mesoblast Limited Sponsored ADR target price is $2.55. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 9 Analysts recommend Mesoblast Limited Sponsored ADR to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Mesoblast Limited Sponsored ADR stock has an average upside potential 2027 of . Most analysts recommend the Mesoblast Limited Sponsored ADR stock at Purchase.

Sales and Margin forecast 2027, 2028 to 2031

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Jun '26 2027
Estimates
Revenue Million $ 120.25 195.44
599.13% 62.53%
Net Margin -47.82% -32.16%
91.95% 32.74%

6 Analysts have issued a sales forecast Mesoblast Limited Sponsored ADR 2027 . The average Mesoblast Limited Sponsored ADR sales estimate is

$195m
unlock
. This is
62.53% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$264m 119.52%
unlock
, the lowest is
$145m 20.62%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2026 $120m 599.13%
2027
$195m 62.53%
unlock
2028
$261m 33.67%
unlock
2029
$458m 75.13%
unlock
2030
$1.2b 159.67%
unlock
2031
$1.8b 51.94%
unlock

6 Mesoblast Limited Sponsored ADR Analysts have issued a net profit forecast 2027. The average Mesoblast Limited Sponsored ADR net profit estimate is

$-62.9m
unlock
. This is
9.32% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$13.6m 123.67%
unlock
, the lowest is
$-152m 165.20%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026 $-57.5m 43.70%
2027
$-62.9m 9.32%
unlock
2028
$300m 577.09%
unlock
2029
$574m 91.41%
unlock

Net Margin

2026 -47.82% 91.95%
2027
-32.16% 32.74%
unlock
2028
114.80% 456.97%
unlock
2029
125.48% 9.30%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2031

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Jun '26 2027
Estimates
Earnings Per Share $ -0.04 -0.05
50.00% 25.00%
P/E negative
EV/Sales 10.68

6 Analysts have issued a Mesoblast Limited Sponsored ADR forecast for earnings per share. The average Mesoblast Limited Sponsored ADR EPS is

$-0.05
unlock
. This is
25.00% lower
unlock
than earnings per share in the financial year 2026. The highest EPS forecast is
$0.01 125.00%
unlock
, the lowest is
$-0.12 200.00%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026 $-0.04 50.00%
2027
$-0.05 25.00%
unlock
2028
$0.23 560.00%
unlock
2029
$0.44 91.30%
unlock

P/E ratio

Current -378.00 77.78%
2027
-311.88 17.49%
unlock
2028
65.37 120.96%
unlock
2029
34.15 47.76%
unlock

Based on analysts' sales estimates for 2027, the Mesoblast Limited Sponsored ADR stock is valued at an EV/Sales of

10.68
unlock
and an P/S ratio of
10.23
unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 17.36 84.68%
2027
10.68 38.45%
unlock
2028
7.99 25.19%
unlock
2029
4.56 42.90%
unlock
2030
1.76 61.49%
unlock
2031
1.16 34.18%
unlock

P/S ratio

Current 16.63 85.57%
2027
10.23 38.47%
unlock
2028
7.65 25.19%
unlock
2029
4.37 42.90%
unlock
2030
1.68 61.49%
unlock
2031
1.11 34.19%
unlock

Current Mesoblast Limited Sponsored ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BELL POTTER SECURITIES
Locked
➜
Locked
Locked Sep 22 2026
CANACCORD GENUITY
Locked
➜
Locked
Locked Sep 05 2026
MAXIM GROUP
Locked
➜
Locked
Locked Sep 03 2026
JEFFERIES
Locked
➜
Locked
Locked Sep 02 2026
CANTOR FITZGERALD
Locked
➜
Locked
Locked Aug 28 2026
PIPER SANDLER COMPANIES
Locked
➜
Locked
Locked Aug 27 2026
PIPER SANDLER COMPANIES
Locked
➜
Locked
Locked Jul 14 2026
Analyst Rating Date
Locked
BELL POTTER SECURITIES:
Locked
➜
Locked
Sep 22 2026
Locked
CANACCORD GENUITY:
Locked
➜
Locked
Sep 05 2026
Locked
MAXIM GROUP:
Locked
➜
Locked
Sep 03 2026
Locked
JEFFERIES:
Locked
➜
Locked
Sep 02 2026
Locked
CANTOR FITZGERALD:
Locked
➜
Locked
Aug 28 2026
Locked
PIPER SANDLER COMPANIES:
Locked
➜
Locked
Aug 27 2026
Locked
PIPER SANDLER COMPANIES:
Locked
➜
Locked
Jul 14 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today